Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
On October 7, MannKind Corporation (NASDAQ:MNKD) stock of was part of top 10 list, albeit the list was for companies which had shrunk the maximum in terms of percentage of their share value. The pressure on the stock of this development stage drug maker has been a sustained one with analysts and the competition casting question marks on the suitability and safety aspects of its target cure of ?inhaled insulin procedure?.
Over the past 30 days Bank of America and Summer Street have downgraded the stock. They have sighted the rough road ahead for the firm in terms of getting its new drug application accepted by FDA and initiate trail of its inhaled insulin cure.
http://www.financialstrend.com/mannkind-corporation-nasdaqmnkd-continues-to-fall-7017.html
It's not a cure!!!!! 😡
Over the past 30 days Bank of America and Summer Street have downgraded the stock. They have sighted the rough road ahead for the firm in terms of getting its new drug application accepted by FDA and initiate trail of its inhaled insulin cure.
http://www.financialstrend.com/mannkind-corporation-nasdaqmnkd-continues-to-fall-7017.html
It's not a cure!!!!! 😡